384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid...

by Yu Xia, Hui Gan, Xiaoping Jin, Amy Prawira, Jermaine Coward, Anna Mislang, Adnan Nagrial, Baiyong Li, Zhongmin Maxwell Wang, Kon Yew Kwek, Dennis Xia
Published 2020-11-01

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

by Linda Mileshkin, Elizabeth Barnes, Tarek Meniawy, Michael Friedlander, Geraldine Goss, Jermaine Coward, Yoland Antill, Michelle Cummins, Sally Baron-Hay, Martin R Stockler, Catherine Shannon, Philip Beale, Peey-Sei Kok, Deborah Smith, Sonia Yip, Amanda Spurdle, Yeh Chen Lee, Janine Lombard, John Andrews
Published 2021-06-01